Guo C-T, Lu Q-B, Ding S-J, Hu C-Y, Hu J-G, Wo Y, Fan Y-D, Wang X-J, Qin S-L, Cui N, Yang Z-D, Zhang X-A, Liu W, Cao W-C
State Key Laboratory of Pathogen and Biosecurity,Beijing Institute of Microbiology and Epidemiology,Beijing,P.R. China.
School of Public Health,Peking University,Beijing,P.R. China.
Epidemiol Infect. 2016 Apr;144(6):1345-54. doi: 10.1017/S0950268815002678. Epub 2015 Nov 6.
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that was caused by a novel bunyavirus, SFTSV. The study aimed to disclose the epidemiological and clinical characteristics of SFTSV infection in China so far. An integrated clinical database comprising 1920 SFTS patients was constructed by combining first-hand clinical information collected from SFTS sentinel hospitals (n = 1159) and extracted data (n = 761) from published literature. The considered variables comprised clinical manifestations, routine laboratory tests of acute infection, hospitalization duration and disease outcome. SFTSV-IgG data from 19 119 healthy subjects were extracted from the published papers. The key clinical variables, case-fatality rate (CFR) and seroprevalence were estimated by meta-analysis. The most commonly seen clinical manifestations of SFTSV infection were fever, anorexia, myalgia, chill and lymphadenopathy. The major laboratory findings were elevated lactate dehydrogenase, aminotransferase, followed by thrombocytopenia, lymphocytopenia, elevated alanine transaminase and creatine kinase. A CFR of 12·2% was estimated, significantly higher than that obtained from national reporting data, but showing no geographical difference. In our paper, the mortality rate was about 1·9 parts per million. Older age and longer delay to hospitalization were significantly associated with fatal outcome. A pooled seroprevalence of 3·0% was obtained, which increased with age, while comparable for gender. This study represents a clinical characterization on the largest group of SFTS patients up to now. A higher than expected CFR was obtained. A wider spectrum of clinical index was suggested to be used to identify SFTSV infection, while the useful predictor for fatal outcome was found to be restricted.
发热伴血小板减少综合征(SFTS)是一种由新型布尼亚病毒SFTSV引起的新发传染病。该研究旨在揭示目前中国SFTSV感染的流行病学和临床特征。通过整合从SFTS哨点医院收集的第一手临床信息(1159例)和从已发表文献中提取的数据(761例),构建了一个包含1920例SFTS患者的综合临床数据库。纳入的变量包括临床表现、急性感染的常规实验室检查、住院时间和疾病转归。从已发表论文中提取了19119名健康受试者的SFTSV-IgG数据。通过荟萃分析估计关键临床变量、病死率(CFR)和血清阳性率。SFTSV感染最常见的临床表现为发热、厌食、肌痛、寒战和淋巴结病。主要实验室检查结果为乳酸脱氢酶、转氨酶升高,其次为血小板减少、淋巴细胞减少、谷丙转氨酶和肌酸激酶升高。估计CFR为12.2%,显著高于国家报告数据,但无地域差异。在我们的研究中,死亡率约为百万分之1.9。年龄较大和住院延迟时间较长与死亡结局显著相关。汇总血清阳性率为3.0%,随年龄增长而升高,男女之间无差异。本研究是迄今为止对最大一组SFTS患者的临床特征描述。获得了高于预期的CFR。建议使用更广泛的临床指标来识别SFTSV感染,而发现的死亡结局有用预测指标有限。